To help celebrate the 25th Anniversary of the Annual Cardiovascular Conference at Lake Louise, conference directors are offering early registrants the opportunity to earn free ski lift tickets.
Here is the deal:
- You earn a free lift ticket for each person who registers after you from now on and provides your name as a reference during the online registration process.
- Each new registrant can only credit one referee.
- Conference directors will have a list of referees and the number of credits for each, and at the conference you will receive the free lift ticket(s).
So encourage your colleagues and friends to register for the conference, and remind them to provide your name as their referee. Once they register, they also become eligible for the lift ticket deal, so everyone wins and the sooner you’re in, the better! Look forward to seeing you March 1-5, 2009.
Register now through the ACC Lake Louise website.
Email to a colleague
The JUPITER (Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin) trial has recently created waves throughout the cardiovascular community. The trial was originally designed to answer a critical clinical question: Can statin drugs prevent cardiovascular disease among healthy people with normal low-density lipoprotein cholesterol levels but an increased level of high-sensitivity C-reactive protein?
Jupiter Trial [2:07m]:
Play in Popup |
Download
Trial results indicate a resounding “yes,” and the question now becomes how clinical practice may change.
- Will the measurement of C-reactive protein now be required in all middle-aged adults?
- Should we expand the use of statin drugs in primary prevention practices?
- Also, is it cost effective to treat healthy people with normal cholesterol levels?
JUPITER was presented by Paul Ridker (Brigham and Women’s Hospital, Boston, MA) at the American Heart Association 2008 Scientific Sessions in New Orleans, LA, and was published simultaneously in the New England Journal of Medicine.
JUPITER trial investigators at ACC Lake Louise in March
This year at ACC Lake Louise, we are pleased to welcome Dr. Ridker as well as fellow JUPITER trial investigator, Dr. Jacques Genest (McGill University Health Centre/Royal Victoria Hospital Montréal, QC), as faculty speakers.
In addition to being available to discuss the results and implications of the JUPITER trial, Dr. Ridker will be presenting talks on “Targeting Inflammation As a Predictor of Risk” and “New Cardiovascular Risk Scoring: The Reynolds Risk Score.”
Dr. Genest, who is also one of the ACC Lake Louise co-directors, will present a talk on “Cardiovascular Risk in HIV and Inflammatory Diseases.”
Visit the conference program page for a full list of this year’s speakers and talks.
Email to a colleague
The 25th Annual Cardiovascular Conference at Lake Louise will be March 1-5, 2009. ACC Lake Louise has been reviewed and approved by the Canadian Cardiovascular Society and is also associated with American College of Cardiology. Participants can claim up to 21 credit hours.
Sunday — Monday — Tuesday — Wednesday — Thursday
Please note that program details provided here are subject to change.
Download the Program Agenda & Syllabus.
[100-page PDF, 7.91MB]
Download the Program Agenda.
[4-page PDF, 228KB]
The conference is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. Read the conference information on meeting objectives and accreditation. You may also be interested in the Advance Program Brochure.
Sunday, March 1
– Registrant Check-In –
2:30 PM 14th Annual Residents’ Research Competition
Sponsored by Novartis
4:00 Introduction and Welcome from the Conference Director
Dr. W. Peter Klinke
Presiding: Dr. W. Peter Klinke
4:30 The Treatment of AMI: What Have We Learned in 50 Years?
Dr. Allan Ross
5:00 Do ACS Guidelines Change Clinical Practice?
Dr. Paul Armstrong
5:30 Reorganizing Acute MI Care: What Next in Canada and the United States
Dr. Chris Granger
6:00 Ronnie Campbell Memorial Lecture
Heart Failure Lost and Found—Discoveries over 25 Years
Dr. Peter Liu
6:30 Faculty Panel Discussion
7:00 Adjourn
Monday, March 2
Presiding: Dr. W. Peter Klinke
7:30 AM Newer Indications and Limitations of Statin Therapy
Dr. David Waters
8:00 Venous Thromboembolic Disease: Diagnosis and Treatment
Dr. Alexander Turpie
8:30 From Darwin to Tilt Table Testing: Pathophysiology and Management of Vasovagal Syncope
Dr. Bernard Gersh
9:00 Looking Forward: Are We Ready for Cardiovascular Vaccines?
Dr. Peter Liu
9:30 Faculty Panel Discussion
10:00 Adjourn
Presiding: Dr. J. Wayne Warnica
4:30 PM The Natural History of Atrial Fibrillation: Is It a Vascular Disease?
Dr. Bernard Gersh
5:00 Pulmonary Vein Ablation for Atrial Fibrillation
Dr. Mario Talajic
5:30 Surgical Treatment of Atrial Fibrillation
Dr. Ralph Damiano, Jr.
6:00 Management of Atrial Fibrillation in Heart Failure
Dr. Mario Talajic
6:30 Faculty Panel Discussion
7:00 Adjourn
Tuesday, March 3
Presiding: Dr. Jacques Genest
7:30 AM Update on Infectious Endocarditis Prophylaxis
Dr. Heidi Connolly
8:00 Novel Anticoagulants: Goodbye, Warfarin!
Dr. Alexander Turpie
8:30 Targeting Inflammation As a Predictor of Risk
Dr. Paul Ridker
9:00 Evaluation of Cardiac Masses
Dr. Heidi Connolly
9:30 Faculty Panel Discussion
10:00 Adjourn
Canadian Cardiovascular Society Workshop
The Many Different Faces of Heart Failure
4:00 Reception
4:30 - 6:00 PM Vignette Presentations
- Chair: Dr. Jonathan Howlett
- Vignette 1: Third Lead or Third Wheel? Should we ‘Synchronize’ my ICD?
Dr. Debra Isaac
- Vignette 2: I wish I had taken my anti-hypertension medications. Now what do I do? “Treat me like it’s 1974.”
Dr. Justin Ezekowitz
- Vignette 3: What do you mean I have heart failure?
Dr. Justin Ezekowitz
- Vignette 4: I only had the flu… what is the big deal?
Dr. Debra Isaac
Wednesday, March 4
Presiding: Dr. Robert Welsh
7:30 AM CABG vs. PCI for Left Main and Three-Vessel Coronary Artery Disease: The Great Debate
Dr. Ralph Damiano, Jr., and Dr. Erick Schampaert
8:00 Clinical Trials: Why They Fail to Meet Expectations
Dr. Chris Granger
8:30 New Approaches to Imaging in Acute Infarction: The Role of CT and MRI
Dr. Matthias Friedrich
9:00 Antithrombotics in Post-PCI Care
Dr. Erick Schampaert
9:30 Winning Entry from the Novartis Residents’ Research Competition
Winner TBA
9:45 Faculty Panel Discussion
10:00 Adjourn
4:00 - 6:00 PM Knowledge Translation Workshops
Case-Based Interactive Exercises with Faculty
- Acute Coronary Syndromes
Dr. Robert Welsh
Dr. Allan Ross
- Challenging Cases
Dr. Paul Fedak
Dr. Debra Isaac
- Management of Atrial Fibrillation
Dr. Mario Talajic
Dr. Bernard Gersh
- Canadian Cardiovascular Pharmacists Network (CCPN) Pharmacotherapy Workshop
Dr. Alexander Turpie
Dr. Reginald Smith
– Gala Dinner with illusionist Brian Michaels –
Thursday, March 5
Presiding: Dr. W. Peter Klinke
7:30 AM The Metabolic Syndrome: What Every Cardiologist Should Know
Dr. David Waters
8:00 Prognosis of Patients with ICDs
Dr. Derek Exner
8:30 Bigger Is Not Better: How to Shrink a Failing Heart
Dr. Paul Fedak
9:00 New Cardiovascular Risk Scoring: The Reynolds Risk Score
Dr. Paul Ridker
9:30 Faculty Panel Discussion
– Closing Remarks and Evaluations –
Email to a colleague
ACC Lake Louise is pleased to have the American College of Cardiology Foundation (ACCF) co-sponsor the 2009 conference. ACC Lake Louise will be working with the ACCF to provide quality continuing medical education for cardiovascular health care professionals.
For 2009, ACC Lake Louise provides a maximum of 21 credit hours, excluding satellites, for those in Canada and the United States.
ACC Lake Louise is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.
The conference provides continuing medical education credit in accordance with the guidelines of the Committee on Accreditation of Canadian Medical Schools and the Accreditation Council for Continuing Medical Education of the United States.
Email to a colleague
Novartis Pharmaceuticals Canada Inc. has recently joined in supporting the 25th Annual Cardiovascular Conference at Lake Louise.
Our thanks to Novartis for making this 2009 international cardiology event possible. As a Bronze Sponsor, Novartis is invited to actively participate at the Lake Louise meeting and also enjoys additional credit, branding and promotional opportunities before and during the conference itself.
The Cardiovascular Conference at Lake Louise is also pleased to have Novartis sponsor our 14th Annual Residents’ Research Competition.
Here’s to a successful partnership in furthering heart research and continuing medical education!
——
For a current listing of corporate sponsors and sponsorship information, please visit our page on sponsors.
Email to a colleague
GlaxoSmithKline Inc. has recently joined in supporting the 25th Annual Cardiovascular Conference at Lake Louise.
Our thanks to GlaxoSmithKline for making this 2009 international cardiology event possible. As a Bronze Sponsor, GlaxoSmithKline is invited to actively participate at the Lake Louise meeting and also enjoys additional credit, branding and promotional opportunities before and during the conference itself.
Here’s to a successful partnership in furthering heart research and continuing medical education!
——
For a current listing of corporate sponsors and sponsorship information, please visit our page on sponsors.
Email to a colleague
Astellas Pharma Inc. has recently joined in supporting the 25th Annual Cardiovascular Conference at Lake Louise.
Our thanks to Astellas Pharma for making this 2009 international cardiology event possible. As a Bronze Sponsor, Astellas Pharma is invited to actively participate at the Lake Louise meeting and also enjoys additional credit, branding and promotional opportunities before and during the conference itself.
Here’s to a successful partnership in furthering heart research and continuing medical education!
——
For a current listing of corporate sponsors and sponsorship information, please visit our page on sponsors.
Email to a colleague
Roche Canada has recently joined in supporting the 25th Annual Cardiovascular Conference at Lake Louise.
Our thanks to Roche for making this 2009 international cardiology event possible. As a Bronze Sponsor, Roche is invited to actively participate at the Lake Louise meeting and also enjoys additional credit, branding and promotional opportunities before and during the conference itself.
Here’s to a successful partnership in furthering heart research and continuing medical education!
——
For a current listing of corporate sponsors and sponsorship information, please visit our page on sponsors.
Email to a colleague
Pfizer Canada Inc. has recently joined in supporting the 25th Annual Cardiovascular Conference at Lake Louise.
Our thanks to Pfizer for making this 2009 international cardiology event possible. As a Bronze Sponsor, Pfizer is invited to actively participate at the Lake Louise meeting and also enjoys additional credit, branding and promotional opportunities before and during the conference itself.
Here’s to a successful partnership in furthering heart research and continuing medical education!
——
For a current listing of corporate sponsors and sponsorship information, please visit our page on sponsors.
Email to a colleague
